Validation of a velocity-based algorithm to quantify saccades during walking and turning in mild traumatic brain injury and healthy controls.


Journal

Physiological measurement
ISSN: 1361-6579
Titre abrégé: Physiol Meas
Pays: England
ID NLM: 9306921

Informations de publication

Date de publication:
26 04 2019
Historique:
pubmed: 4 4 2019
medline: 31 3 2020
entrez: 4 4 2019
Statut: epublish

Résumé

Saccadic (fast) eye movements are a routine aspect of neurological examination and are a potential biomarker of mild traumatic brain injury (mTBI). Objective measurement of saccades has become a prominent focus of mTBI research, as eye movements may be a useful assessment tool for deficits in neural structures or processes. However, saccadic measurement within mobile infra-red (IR) eye-tracker raw data requires a valid algorithm. The objective of this study was to validate a velocity-based algorithm for saccade detection in IR eye-tracking raw data during walking (straight ahead and while turning) in people with mTBI and healthy controls. Eye-tracking via a mobile IR Tobii Pro Glasses 2 eye-tracker (100 Hz) was performed in people with mTBI (n  =  10) and healthy controls (n  =  10). Participants completed two walking tasks: straight walking (walking back and forth for 1 min over a 10 m distance), and walking and turning (turns course included 45°, 90° and 135° turns). Five trials per subject, for one-hundred total trials, were completed. A previously reported velocity-based saccade detection algorithm was adapted and validated by assessing agreement between algorithm saccade detections and the number of correct saccade detections determined from manual video inspection (ground truth reference). Compared with video inspection, the IR algorithm detected ~97% (n  =  4888) and ~95% (n  =  3699) of saccades made by people with mTBI and controls, respectively, with excellent agreement to the ground truth (intra-class correlation coefficient This study provides a simple yet highly robust algorithm for the processing of mobile eye-tracker raw data in mTBI and controls. Future studies may consider validating this algorithm with other IR eye-trackers and populations.

Identifiants

pubmed: 30943463
doi: 10.1088/1361-6579/ab159d
pmc: PMC7608620
mid: NIHMS1639547
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Validation Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

044006

Subventions

Organisme : Parkinson's Disease Foundation
ID : PF-FBS-1898
Pays : United States
Organisme : NIGMS NIH HHS
ID : RL5 GM118963
Pays : United States
Organisme : NIGMS NIH HHS
ID : TL4 GM118965
Pays : United States
Organisme : NIGMS NIH HHS
ID : UL1 GM118964
Pays : United States

Références

Invest Ophthalmol. 1974 Aug;13(8):619-23
pubmed: 4841869
Neurology. 2015 Sep 29;85(13):1163-6
pubmed: 26320202
Behav Res Methods. 2017 Feb;49(1):258-266
pubmed: 26705117
Invest Ophthalmol Vis Sci. 1981 Jul;21(1 Pt 1):116-25
pubmed: 7251295
Physiol Meas. 2017 Jan;38(1):N16-N31
pubmed: 27941232
Neurol Clin Pract. 2015 Feb;5(1):25-34
pubmed: 29443175
J Vestib Res. 1996 Jul-Aug;6(4):295-313
pubmed: 8839825
Brain Lang. 1989 May;36(4):592-603
pubmed: 2720372
Eur J Neurosci. 2017 Jul;46(1):1703-1716
pubmed: 28444834
Prog Neurol Surg. 2014;28:226-33
pubmed: 24923406
Med Eng Phys. 2016 Mar;38(3):308-15
pubmed: 26786676
Optometry. 2007 Apr;78(4):155-61
pubmed: 17400136
J Neurol Sci. 2016 Feb 15;361:79-86
pubmed: 26810521
Comput Biol Med. 1991;21(1-2):43-9
pubmed: 2044360
Physiol Meas. 2018 Dec 21;39(12):12TR01
pubmed: 30523971
Trends Neurosci. 2011 Apr;34(4):210-24
pubmed: 21439656
Exp Brain Res. 1998 Aug;121(4):391-400
pubmed: 9746145
Eur J Neurosci. 2018 Apr;47(7):769-778
pubmed: 29431890
Behav Res Methods. 2017 Apr;49(2):616-637
pubmed: 27193160
Annu Int Conf IEEE Eng Med Biol Soc. 2014;2014:5739-42
pubmed: 25571299
J Head Trauma Rehabil. 2010 Jul-Aug;25(4):293-305
pubmed: 20611047
Behav Res Methods Instrum Comput. 2002 Nov;34(4):613-7
pubmed: 12564564
J Neuroophthalmol. 2015 Mar;35(1):73-81
pubmed: 25675308
Clin Pediatr (Phila). 2016 Mar;55(3):260-7
pubmed: 26156977
Vision Res. 2010 Dec;50(24):2766-74
pubmed: 20932993
Br J Sports Med. 2007 Sep;41(9):610-2
pubmed: 17496064
Trends Cogn Sci. 2005 Apr;9(4):188-94
pubmed: 15808501
J Neurotrauma. 2018 May 15;35(10):1167-1177
pubmed: 29078732
Behav Res Methods. 2011 Jun;43(2):372-83
pubmed: 21302023
J Head Trauma Rehabil. 2016 Jul-Aug;31(4):252-61
pubmed: 26291632
Neurosci Biobehav Rev. 2016 Mar;62:76-88
pubmed: 26773722
Physiol Meas. 2019 Feb 26;40(2):02TR01
pubmed: 30695760
J Neurosci Methods. 2014 Jan 30;222:175-88
pubmed: 24291711
J Vis. 2017 Jan 1;17(1):28
pubmed: 28114501
Exp Brain Res. 1990;82(1):97-106
pubmed: 2257917
Neurosci Lett. 2007 Apr 24;417(1):61-5
pubmed: 17363165
IEEE Trans Biomed Eng. 2010 Nov;57(11):
pubmed: 20667803
Behav Res Methods. 2010 Feb;42(1):188-204
pubmed: 20160299

Auteurs

Samuel Stuart (S)

Department of Neurology, Oregon Health and Science University, Portland, OR, United States of America. Veterans Affairs Portland Health Care System, Portland, OR, United States of America. Author to whom any correspondence should be addressed.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH